FERMENTA BIOTECH LIMITED

BSE: FERMENTA506414ISIN INE225B01021

Healthcare
Pharmaceuticals
BSE Healthcare

Share price

₹439.00+11.45 (+2.68%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹582.95
52W low: ₹256.40
Off 52W high: -24.69%
1M return: -21.00%
3M return: -20.42%
6M return: +45.70%
1Y return: +54.44%
20D avg volume: 7,618
50 DMA: ₹486.14
200 DMA: ₹388.09

Key ratios Consolidated

Market cap: ₹1,292 Cr
Current price: ₹439.00
52W high / low: ₹582.95 / ₹256.40
Face value: ₹5.00
P/E: 22.21
P/B: 3.27
EPS (TTM): ₹19.77
Book value / share: ₹134.30
ROE: —
ROCE: 24.40%
Operating margin: —
Net margin: —
Debt / equity: 0.27
Net debt: ₹77.20 Cr
Interest cover: 9.31
Dividend yield: 0.85%
Dividend / share (TTM): ₹3.75
Payout: 18.97%
Cash conversion cycle: 129.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	121.82	121.58	137.36	130.22	136.26	139.85	156.47	95.03	78.13	97.34	98.97	56.91
	4.37	5.06	3.12	5.43	8.77	3.89	2.23	2.88	2.82	4.78	2.52	1.90
	126.19	126.65	140.48	135.66	145.03	143.74	158.70	97.91	80.95	102.11	101.49	58.80
	111.50	109.51	120.80	111.57	116.95	111.76	113.36	86.09	86.88	101.20	85.42	80.44
	38.75	37.14	51.24	32.83	22.57	50.49	22.55	18.66	27.19	29.70	12.80	13.56
	9.78	1.48	9.92	16.63	15.62	19.88	21.60	14.00	4.18	7.34	8.32	6.61
	23.01	21.33	20.77	20.14	20.35	16.89	16.98	15.46	15.78	14.86	14.62	14.37
	2.54	2.82	3.04	2.58	3.10	2.99	4.08	3.69	3.43	3.39	5.18	3.69
	5.20	5.11	5.37	5.41	5.81	5.87	6.08	6.15	6.12	6.46	6.38	5.93
	38.70	38.53	40.01	36.88	40.64	35.88	44.02	34.91	32.36	38.67	27.69	25.26
	14.69	17.14	19.68	24.08	28.09	31.98	45.34	11.82	-5.93	0.91	16.07	-21.64
	0.00	9.07	-2.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-7.43
	14.69	26.21	17.48	24.08	28.09	31.98	45.34	11.82	-5.93	0.91	16.07	-29.07
	5.16	7.61	5.46	6.05	6.49	-1.34	7.45	0.70	0.00	8.05	6.08	0.00
	9.53	18.60	12.02	18.03	21.60	33.32	37.89	11.12	-5.93	-7.14	9.99	-29.07
	3.40	6.66	4.36	6.48	7.49	11.79	12.71	3.94	-2.01	-2.41	3.41	-9.63
Key metrics
	22.43	34.14	25.89	32.07	37.00	40.84	55.50	21.66	3.62	10.76	27.63	-19.45
	18.40%	28.10%	18.80%	24.60%	27.20%	29.20%	35.50%	22.80%	4.60%	11.10%	27.90%	-34.20%
	7.80%	15.30%	8.80%	13.80%	15.90%	23.80%	24.20%	11.70%	-7.60%	-7.30%	10.10%	-51.10%
	—	6.60%	—	6.20%	—	8.70%	—	—	—	—	—	—
	-10.60%	-13.10%	-12.20%	37.00%	74.40%	43.70%	58.10%	67.00%	—	—	—	—
	-55.90%	-44.20%	-68.30%	62.10%	464.20%	566.70%	279.30%	138.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	510.98	525.43	469.48	335.66	349.94	398.52
	17.98	22.39	11.82	11.20	7.69	8.14
	528.98	547.82	481.30	346.86	357.64	406.65
	453.38	458.83	398.09	349.31	381.04	379.71
	159.96	148.76	118.91	77.00	112.02	132.19
	37.81	43.64	59.66	27.02	19.02	14.70
	85.25	82.59	65.10	58.55	57.91	62.97
	10.98	11.54	14.19	17.05	20.78	17.08
	21.09	21.70	24.22	24.72	28.25	25.56
	154.12	151.07	147.17	118.86	120.54	118.81
	75.59	88.98	83.21	-2.45	-23.40	26.94
	6.87	6.88	0.00	-7.43	-28.48	0.00
	82.46	95.86	83.21	-9.87	-51.87	26.94
	24.28	25.61	6.80	14.14	1.68	11.88
	58.18	70.25	76.40	-24.01	-53.55	15.06
	20.90	24.70	26.35	-7.99	-17.85	5.35
Key metrics
	114.53	129.10	121.62	31.90	-2.84	69.58
	22.41%	24.60%	25.90%	9.50%	-0.80%	17.50%
	11.39%	13.40%	16.30%	-7.20%	-15.30%	3.80%
	—	24.40%	24.20%	—	—	—
	-3.15%	11.90%	39.90%	-4.10%	-12.20%	—
	-44.02%	-8.00%	418.20%	55.20%	-455.60%	—
	—	62.50	18.77	—	—	—
	—	1.32	0.54	—	—	—
	—	0.27	0.31	—	—	—
	—	77.20	81.16	—	—	—
	—	129.9	109.9	—	—	—
Balance sheet
	—	647.94	614.48	—	—	—
	—	388.02	335.23	—	—	—
	—	31.69	28.24	—	—	—
	—	111.59	95.23	—	—	—
	—	152.54	123.65	—	—	—
	—	29.23	28.17	—	—	—
	—	205.62	210.06	—	—	—
	—	77.15	77.49	—	—	—
	—	207.04	211.88	—	—	—
	—	108.89	109.40	—	—	—
	—	100.99	94.35	—	—	—
	—	7.90	15.05	—	—	—
	—	400.55	358.52	—	—	—
Cash flow
	—	92.83	40.90	—	—	—
	—	-43.00	-0.16	—	—	—
	—	-42.29	-50.87	—	—	—
	—	30.33	22.13	—	—	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	111.84	109.88	114.24	107.12	119.02	122.04	146.25	89.54	72.70	89.66	89.35	51.31
	4.90	6.10	3.43	5.53	8.84	3.88	2.22	2.95	2.63	1.50	2.58	2.03
	116.74	115.98	117.67	112.64	127.86	125.92	148.47	92.49	75.33	91.15	91.93	53.33
	96.59	95.89	98.98	91.87	105.14	97.95	106.03	83.63	80.18	90.35	74.15	72.32
	44.86	36.42	49.09	41.51	29.43	35.40	35.59	30.98	27.01	32.10	13.37	15.74
	1.30	2.32	5.64	5.94	5.36	7.17	5.40	3.24	1.43	0.88	3.62	2.26
	20.05	18.32	18.12	18.73	18.97	15.59	15.74	14.22	14.55	13.68	13.47	13.23
	2.54	2.77	3.03	2.59	3.10	2.99	4.09	3.69	3.42	3.41	5.16	3.72
	5.19	5.08	5.17	5.13	5.55	5.60	5.82	5.89	5.86	6.20	6.13	5.68
	33.28	34.83	32.98	32.87	33.63	31.56	39.08	30.96	30.09	37.36	25.36	23.07
	20.15	20.09	18.70	20.77	22.72	27.97	42.44	8.86	-4.85	0.81	17.78	-18.98
	0.00	9.07	-2.11	0.00	0.00	0.00	—	—	—	—	—	-9.00
	20.15	29.16	16.59	20.77	22.72	27.97	42.44	8.86	-4.85	0.81	17.78	-27.98
	5.16	7.59	4.83	6.05	6.49	1.34	7.45	0.70	—	8.05	6.08	—
	14.99	21.57	11.76	14.72	16.23	29.31	35.00	8.16	-4.85	-7.25	11.70	-27.98
	5.23	7.49	4.04	5.05	5.57	10.05	12.05	2.81	-1.68	-2.51	4.05	-9.69
Key metrics
	27.88	37.01	24.79	28.49	31.37	36.56	52.35	18.44	4.43	10.42	29.07	-18.58
	24.90%	33.70%	21.70%	26.60%	26.40%	30.00%	35.80%	20.60%	6.10%	11.60%	32.50%	-36.20%
	13.40%	19.60%	10.30%	13.70%	13.60%	24.00%	23.90%	9.10%	-6.70%	-8.10%	13.10%	-54.50%
	—	6.90%	—	5.20%	—	7.30%	—	—	—	—	—	—
	-6.00%	-10.00%	-21.90%	19.60%	63.70%	36.10%	63.70%	74.50%	—	—	—	—
	-7.60%	-26.40%	-66.40%	80.40%	434.60%	504.30%	199.10%	129.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22
Income statement
	443.08	450.25	430.53	307.09	328.92	387.96
	19.96	23.90	11.68	8.15	7.56	7.53
	463.03	474.15	442.21	315.25	336.48	395.49
	383.33	391.88	367.79	310.85	335.58	352.92
	171.88	166.57	128.98	83.79	100.49	133.13
	15.20	11.50	17.24	7.78	8.73	3.42
	75.22	74.14	60.10	53.93	53.72	59.36
	10.93	11.48	14.20	17.05	20.94	17.23
	20.57	20.94	23.17	23.70	24.51	23.67
	133.96	131.96	131.69	110.74	109.90	106.51
	79.71	82.28	74.42	4.39	0.90	42.56
	6.96	6.97	0.00	-9.00	-59.59	—
	86.67	89.24	74.42	-4.61	-58.69	42.56
	23.63	24.96	6.80	14.14	1.16	12.32
	63.04	64.28	67.62	-18.74	-57.53	30.24
	21.81	22.13	23.18	-6.49	-19.94	10.48
Key metrics
	118.17	121.66	111.79	36.14	-13.24	83.46
	26.67%	27.00%	26.00%	11.80%	-4.00%	21.50%
	14.23%	14.30%	15.70%	-6.10%	-17.50%	7.80%
	—	21.90%	20.90%	—	—	—
	-7.08%	4.60%	40.20%	-6.60%	-15.20%	—
	-28.93%	-4.90%	460.80%	67.40%	-290.20%	—
	—	52.32	11.70	—	—	—
	—	1.29	0.50	—	—	—
	—	0.26	0.29	—	—	—
	—	100.01	90.90	—	—	—
	—	165.6	127.5	—	—	—
Balance sheet
	—	652.36	622.47	—	—	—
	—	359.51	320.52	—	—	—
	—	8.88	18.50	—	—	—
	—	137.21	120.21	—	—	—
	—	130.66	94.48	—	—	—
	—	20.26	0.00	—	—	—
	—	205.50	210.06	—	—	—
	—	63.51	64.28	—	—	—
	—	191.47	198.43	—	—	—
	—	108.89	109.40	—	—	—
	—	100.99	94.35	—	—	—
	—	7.90	15.05	—	—	—
	—	422.82	379.95	—	—	—
Cash flow
	—	82.63	33.83	—	—	—
	—	-44.50	0.41	—	—	—
	—	-42.15	-50.91	—	—	—
	—	30.31	22.13	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +11.03%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -7.08%
Profit YoY (TTM): -28.93%

Consolidated

Sales CAGR 3Y: +14.51%
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -3.15%
Profit YoY (TTM): -44.02%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 60.12%

Quarter	September 2026	June 2026
Promoter %	60.12%	64.08%

Holder	Type	Holding	Previous	Change
Krishna Datla	Promoter	36.04%	36.04%	0.00%
Satish Varma Azad Nadimpally	Promoter	11.73%	11.73%	0.00%
Anupama Datla Desai	Promoter	8.70%	8.70%	0.00%
Preeti Thakkar	Promoter	3.65%	7.61%	-3.96%
Fermenta Biotech Limited Esop Trust	Public	2.39%	2.55%	-0.16%
Rakesh Kantilal Shah	Public	1.72%	1.76%	-0.04%
Anant Jain	Public	1.53%	—	—
Krishan Premnarayen .	Public	1.38%	1.38%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
FERMENTA BIOTECH LIMITED	1,292	439.00	22.21	24.40%	-3.15% TTM	-44.02% TTM	+54.44%

Filings & corporate actions

Recent announcements

Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve unaudited financial results ....29 Oct 2026 · Board Meeting / Board Meeting
We hereby submit newspaper publication pertaining to Notice for Special window for transfer and dematerialization of physical securities.27 Oct 2026 · Company Update / Newspaper Publication
Intimation of investor(s) meeting to be held on October 15, 2026.12 Oct 2026 · Company Update / Analyst / Investor Meet
Intimation of investor(s) meeting(s) to be held on October 14, 2026.9 Oct 2026 · Company Update / Analyst / Investor Meet
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of investor(s) meeting to be held on October 07, 2026.1 Oct 2026 · Company Update / Analyst / Investor Meet
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Preeti Thakkar30 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Intimation of investor meeting to be held on October 5, 2026.29 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of Closure of Trading Window.29 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of investor(s) meeting.24 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of investor(s) meeting.21 Sep 2026 · Company Update / Analyst / Investor Meet
Intimation of investor(s) meet.17 Sep 2026 · Company Update / Analyst / Investor Meet
Copy of Newspaper Publication regarding notice to equity shareholders for transfer of shares to IEPF.16 Sep 2026 · Company Update / Newspaper Publication
Dispatch of Letters to shareholders regarding transfer of Equity Shares of the Company to the Investor Education and Protection Fund (''IEPF'') account.16 Sep 2026 · Company Update / General
Press Release regarding exclusive Licence Agreement with Vellore Institute of Technology (''VIT''), Vellore for Vitamin B12 Fortification Technology.8 Sep 2026 · Company Update / General
Intimation of investor(s) meeting(s) to be held on September 3, 2026.27 Aug 2026 · Company Update / Analyst / Investor Meet
We hereby submit newspaper publication pertaining to Notice for Special window for transfer and dematerialization of physical securities.26 Aug 2026 · Company Update / Newspaper Publication
Intimation of investor meeting to be held on August 21, 2026.17 Aug 2026 · Company Update / Analyst / Investor Meet
Revision in credit rating.17 Aug 2026 · Company Update / Credit Rating
Newspaper publication of Unaudited financial results for quarter ended June 30, 2026.12 Aug 2026 · Company Update / Newspaper Publication
Declaration of voting results of the 74th Annual General Meeting.11 Aug 2026 · AGM/EGM / AGM
Scrutinizers report of 74th Annual General Meeting.11 Aug 2026 · AGM/EGM / AGM
Outcome of 74th Annual General Meeting.11 Aug 2026 · AGM/EGM / AGM
Presentation for shareholders at 74th Annual General Meeting (''AGM'')11 Aug 2026 · Company Update / General
Earnings presentation - Q1/FY2711 Aug 2026 · Company Update / Investor Presentation
Press release regarding unaudited financial results of Q1FY27.11 Aug 2026 · Company Update / Press Release / Media Release
Unaudited financial results for quarter ended June 30, 2026.11 Aug 2026 · Result / Financial Results
Outcome of Board meeting and unaudited financial results - June 30, 2026.11 Aug 2026 · Board Meeting / Outcome of Board Meeting
Intimation of investor(s) meeting(s).10 Aug 2026 · Company Update / Analyst / Investor Meet
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve unaudited financial results ....4 Aug 2026 · Board Meeting / Board Meeting
Press release - listing of shares on NSE4 Aug 2026 · Company Update / Press Release / Media Release
Intimation regarding listing of equity shares of Fermenta Biotech Limited on National Stock Exchange of India Limited.31 Jul 2026 · Company Update / General
Intimation of investor meeting24 Jul 2026 · Company Update / Analyst / Investor Meet
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we enclose herewith photocopy of the newspaper advertisement published pertaining ....21 Jul 2026 · Company Update / Newspaper Publication
Business Responsibility and Sustainability Reporting for Financial Year 2025-26.20 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Notice of the 74th Annual General Meeting of Fermenta Biotech Limited to be held on August 11, 2026.20 Jul 2026 · AGM/EGM / AGM
Annual Report for Financial Year 2025-26.20 Jul 2026 · Others / Reg. 34 (1) Annual Report
Cessation of subsidiary being a wholly-owned subsidiary pursuant to Share Subscription Agreement entered on July 20, 2026.20 Jul 2026 · Company Update / General
Intimation of investor(s) meeting to be held on July 23, 2026.17 Jul 2026 · Company Update / Analyst / Investor Meet
Intimation of investor(s) meeting to be held on July 22, 2026.17 Jul 2026 · Company Update / Analyst / Investor Meet

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 3.7500	5 Aug 2026	5 Aug 2026	—
Final Dividend - Rs. - 2.5000	6 Aug 2025	6 Aug 2025	—
Final Dividend - Rs. - 1.2500	6 Aug 2024	6 Aug 2024	—

Board meetings

5 Nov 2026 Board Meeting - Financial Results
11 Aug 2026 Board Meeting - Financial Results